Aim: This study is aimed at determining the total PSA (tPSA), free PSA (fPSA) concentrations and free to total PSA ratio (f/tPSA) and their utility in prostate cancer (PCa) risk stratification among male lepromatous leprosy patients in Edo state, Nigeria. Methods: Forty participants and thirty controls participated in this study. A structured questionnaire was administered to each participant to elicit details such as their personal data, age, sex, residence, medications, alcohol consumption, smoking habit, length of time of diagnosis, sexual activities, as well as the history of any other underlying diseases. Blood samples were collected from the participants. Total and free PSA concentrations in the samples were measured using ELISA method. Results: Significantly (p = 0.042) higher serum fPSA among the leprosy patients (0.22 ± 0.12 ng/ml) compared with the healthy controls (0.17 ± 0.09 ng/ml). There were no significant (p = 0.055) difference in the mean tPSA between the leprosy patients (2.69 ± 2.25 ng/ml) compared with the control (1.95 ± 0.69 ng/ml). Similarly, no significant (p = 0.548) difference was observed in PSA ratio between the control (0.08 ± 0.04) and the leprosy patients (0.09 ± 0.03). Conclusion: Our study indicated no significant differences in tPSA and f/tPSA between the leprosy patients and their healthy control. Elevated tPSA as well as f/tPSA levels that fell within the high risk zones of PCa were more prevalent among patients aged ≥ 70 years, not married, who rarely had sexual intercourse and those with longer disease duration.
Bassukas, I.D., Gaitanis, G. and Hundeiker, M. (2012) Leprosy and the Natural Selection for Psoriasis. Medical Hypotheses, 78, 183-190. https://doi.org/10.1016/j.mehy.2011.10.022
Nigeria Centre for Disease Control (2017) Leprosy. NCDC. https://ncdc.gov.ng/diseases/factsheet/33
Forno, C., Hausermann, P., Hatz, C., et al. (2010) The Difficulty in Diagnosis and Treatment of Leprosy. Journal of Travel Medicine, 17, 281-283. https://doi.org/10.1111/j.1708-8305.2010.00419.x
Saporta, L. and Yuksel, A. (1994) Androgenic Status in Patients with Lepromatous Leprosy. British Journal of Urology, 74, 221-224. https://doi.org/10.1111/j.1464-410X.1994.tb16590.x
Abd-Elkawi, F.A., Bahgat, S.A., Kamel, A.M., Farag, A.S. and Ashor, O.M. (2014) Testicular Function in Male Patients with Lepromatous Leprosy. Egyptian Journal of Dermatology and Venerology, 34, 41-45. https://doi.org/10.4103/1110-6530.137307
Akinremi, T.O., Adeniyi, A., Olutunde, A., Oduniyi, A. and Ogo, C.N. (2014) Need for and Relevance of Prostate Cancer Screening in Nigeria. Ecancer, 8, 457.
Ugochukwu, U.V., Odukoya, O.O., Ajogwu, A. and Ojewola, R.W. (2019) Prostate Cancer Screening: What Do Men Know, Think and Do about Their Risk? Exploring the Opinions of Men in an Urban Area in Lagos State, Nigeria: A Mixed Methods Survey. Pan African Medical Journal, 34, 168. https://doi.org/10.11604/pamj.2019.34.168.20921
Ogunbiyi, J.O. and Shittu, O.B. (1999) Increased Incidence of Prostate Cancer in Nigerians. Journal of the National Medical Association, 91, 159-164.
Streicher, J., Meyerson, B.L., Karivedu, V. and Sidana, A. (2019) A Review of Optimal Prostate Biopsy Indications and Techniques. Therapeutic Advances in Urology, 11, 1-8. https://doi.org/10.1177/1756287219870074
U.S. Department of Health and Human Services. Prostate-Specific Antigen (PSA) Test. National Cancer Institute Fact Sheet. https://www.cancer.gov/types/prostate/psa-fact-sheet
Catalona, W., Partin, A., Slawin, K., et al. (1998) Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer from Benign Prostatic Disease: A Prospective Multicenter Clinical Trial. JAMA, 279, 1542-1547. https://doi.org/10.1001/jama.279.19.1542
Hoffman, R.M., Clannon, D.L., Littenberg, B., Frank, J.J. and Pierce, J.C. (2000) Using the Free to Total Prostate Specific Antigen Ratio to Detect Prostate Cancer in Men with Non-Specific Elevations of Prostate Specific Antigen Level. Journal of General Internal Medicine, 15, 739-748. https://doi.org/10.1046/j.1525-1497.2000.90907.x
McCormack, R.T., Rittenhouse, H.G., Finlay, J.A., et al. (1995) Molecular Forms of Prostate-Specific Antigen and the Human Kallikrein Gene Family: A New Era. Urology, 45, 729-744. https://doi.org/10.1016/S0090-4295(99)80076-4
Vessella, R.L., Lange, P.H., et al. (1997) Issues in the Assessment of Prostate-Specific Antigen Immunoassays. An Update. Urologic Clinics of North America, 24, 261-268. https://doi.org/10.1016/S0094-0143(05)70371-2
Ikuerowo, S.O., Omisanjo, O.A., Bioku, M.J., Ajala, M.O., Mordi, V.P.N. and Esho, J.O. (2013) Prevalence and Characteristics of Prostate Cancer among Participants of a Community-Based Screening in Nigeria Using Serum Prostate Specific Antigen and Digital Rectal Examination. The Pan African Medical Journal, 15, 129. https://doi.org/10.11604/pamj.2013.15.129.2489
Ajape, A.A., Babata, A. and Abiola, O.O. (2010) Knowledge of Prostate Cancer Screening among Native African Urban Population in Nigeria. Nigerian Quarterly Journal of Hospital Medicine, 20, 94-96. https://doi.org/10.4314/nqjhm.v20i2.58044
Ukoli, F., Osime, U., Akereyeni, F., Okunzuwa, O., Kittles, R. and Adams-Campbell, L. (2003) Prevalence of Elevated Serum Prostate-Specific Antigen in Rural Nigeria. International Journal of Urology, 10, 315-322. https://doi.org/10.1046/j.1442-2042.2003.00633.x
Erdogan, A., Cemal, T., Mehmet, O.Y., Cavit, C. and Ilker, E. (2014) Prostatic and Testicular Parameters in Lepromatous Patients. Leprosy Review, 85, 48-53. https://doi.org/10.47276/lr.85.1.48
Thompson, I.M., Pauler, D.K., Goodman, P.J., et al. (2004) Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level https://doi.org/10.1056/NEJMoa031918
Adhyam, M. and Gupta, A.K. (2012) A Review on the Clinical Utility of PSA in Cancer Prostate. Indian Journal of Surgical Oncology, 3, 120-129. https://doi.org/10.1007/s13193-012-0142-6
Center for Disease Control and Prevention. Who Is at Risk for Prostate Cancer? https://www.cdc.gov/cancer/prostate/basic_info/risk_factors.htm
Baruah, S.K., Nath, S.J., Puthenveetil, R.T., Baruah, S.J., Deka, P.M. and Bawri, B. (2012) Correlation of Age, Prostate Volume, Serum Prostate-Specific Antigen, and Serum Testosterone in Indian, Benign Prostatic Hyperplasia Patients. UroToday International Journal, 5, 1-6. https://doi.org/10.3834/uij.1944-5784.2012.10.02
Lee, S.E., Chung, J.S., Han, B.K., Moon, K.H., Hwang, S.I. and Lee, H.J. (2008) Relationship of Prostate-Specific Antigen and Prostate Volume in Korean Men with Biopsy-Proven Benign Prostatic Hyperplasia. Urology, 71, 395-398. https://doi.org/10.1016/j.urology.2007.10.019
Hyun, J.S. (2012) Prostate Cancer and Sexual Function. The World Journal of Men’s Health, 30, 99-107. https://doi.org/10.5534/wjmh.2012.30.2.99
Tsitouras, P.D., Martin, C.E. and Harman, S.M. (1982) Relationship of Serum Testosterone to Sexual Activity in Healthy Elderly Men. The Journals of Gerontology, 37, 288-293. https://doi.org/10.1093/geronj/37.3.288
Gades, N.M., Jacobson, D.J., McGree, M.E., et al. (2008) The Associations between Serum Sex Hormones, Erectile Function, and Sex Drive: The Olmsted County Study of Urinary Symptoms and Health Status among Men. The Journal of Sexual Medicine, 5, 2209-2220. https://doi.org/10.1111/j.1743-6109.2008.00924.x
O’Connor, D.B., Lee, D.M., Corona, G., et al. (2011) The Relationships between Sex Hormones and Sexual Function in Middle-Aged and Older European Men. The Journal of Clinical Endocrinology & Metabolism, 96, E1577-E1587.
Kiriyama, I., Ohgaki, K., Ohba, S., et al. (2003) Prostate Cancer in Patients with Hansen’s Disease. International Journal of Urology, 10, 177-179. https://doi.org/10.1046/j.1442-2042.2003.00584.x
Massengill, J.C., Sun, L., Moul, J.W., Wu, H., McLeod, D.G., Amling, C., et al. (2003) Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients with Localized Prostate Cancer Treated with Radical Prostatectomy. Journal of Urology, 169, 1670-1676. https://doi.org/10.1097/01.ju.0000062674.43964.d0
Morgentaler, A., Bruning, C.O. and DeWolf, W.C. (1996) Occult Prostate Cancer in Men with Low Serum Testosterone Levels. JAMA, 276, 1904-1906. https://doi.org/10.1001/jama.276.23.1904
Yamamoto, S., Yonese, J., Kawakami, S., Ohkubo, Y., Tatokoro, M., et al. (2007) Preoperative Serum Testosterone Levels as an Independent Predictor of Treatment Failure Following Radical Prostatectomy. European Urology, 52, 696-701. https://doi.org/10.1016/j.eururo.2007.03.052